Relafen 750, or advanced formulation of naproxen, represents a compelling study from our biochemical pharmacy view. Its mode of action, mainly involving suppression of cyclooxygenase enzymes namely COX-1 and COX-2 – contributes to significant reduction in prostaglandin production. From the biochemical context, this drug's effectiveness is closely